Through that experience, I got an up-close view of how software engineering teams work, how good products are launched, and ...

E-readers are an awesome creation allowing you to display digital information in a way that requires little battery life. While there’s plenty of very impressive models to chose from on the ...

Editor's take: Microsoft is having a tough time leaving Windows Notepad well enough alone. The classic text editor is effectively gone, replaced by a "new" version that keeps accumulating a growing ...

The holidays are over, but there's a reason for kids (and grown-ups!) to keep hope alive — snow days! Whether you have a full day off to enjoy the fluffy white stuff or a remote learning session you ...

Hulu’s latest true-crime docuseries revisits one of the most dramatic prison escapes in recent memory. “Girl on the Run: The Hunt for America’s Most Wanted Woman” premieres Thursday, Feb. 19, ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Notepad++ has released a security fix to plug gaps that were exploited by an advanced threat actor from China to hijack the software update mechanism to selectively deliver malware to targets of ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

PCWorld reports that Windows Notepad’s new Markdown support feature has introduced a serious remote code execution vulnerability with a high CVSS score of 8.8/7.7. The security flaw allows malicious ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.